Insider trade

Orchestra Biomed Holdings (OBIO)Director sold ~$95K

Darren Sherman, Director at Orchestra Biomed Holdings, sold ~$95K of Orchestra Biomed Holdings shares.

~$95K
Approx. value · 15K sh @ $6.36
1.12M
Holds after · shares reported
Traded
Oct 1, 2026
Filed
Oct 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 3, 2026InsiderDirector sold ~$61K of OBIO shares in the open market
  2. Aug 26, 2026InsiderDirector purchased ~$11K of OBIO shares in the open market
  3. Sep 1, 2026InsiderDirector sold ~$74K of OBIO shares in the open market
  4. Sep 3, 2026InsiderDirector purchased ~$48K of OBIO shares in the open market
  5. Oct 1, 2026 · this disclosureInsiderDirector sold ~$95K of OBIO shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Orchestra Biomed Holdings

For Orchestra Biomed Holdings, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OBIO page.

Other recent filings by Darren Sherman, See Remarks

The full history of Darren Sherman, See Remarks is on the profile page.

How this filing works

Other disclosures at Orchestra Biomed Holdings

Everything OQRO holds on this company is on its OBIO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data